Literature DB >> 6095867

Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus.

W Sieghart, A Schuster.   

Abstract

The structure-affinity relationship of benzodiazepine receptor ligands for binding to their receptors was investigated by measuring the potency of 41 benzodiazepines or benzodiazepine analogues and of 9 non-benzodiazepines for inhibition of [3H]flunitrazepam binding to cerebellar or hippocampal membranes. It was found that a chloro or a fluoro substitutent in position 2' enhanced whereas substituents in position 3 and substituents larger than a methyl group in position 1 of the benzodiazepine ring system reduced the potency of benzodiazepines for inhibition of [3H]flunitrazepam binding in cerebellum or hippocampus. In addition, several benzodiazepines could be identified which have a higher affinity for benzodiazepine receptors in cerebellum than for those in hippocampus. A selectivity of benzodiazepines for their receptors in cerebellum seems to be caused not only by certain substituents in position 1 but also by a chloro group in position 2' and together with this substituent by a hydroxy group in position 3.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095867     DOI: 10.1016/0006-2952(84)90017-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  20 in total

Review 1.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

2.  Benzodiazepine receptor sites in the chick optic lobe: development and pharmacological characterization.

Authors:  M C Gravielle; S Fiszer de Plazas
Journal:  Neurochem Res       Date:  1991-01       Impact factor: 3.996

3.  The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands.

Authors:  G Griebel; D J Sanger; G Perrault
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

4.  Proceedings of the British Pharmacological Society. 18th-20th December 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

5.  Like diazepam, CL 218,872, a selective ligand for the benzodiazepine omega 1 receptor subtype, impairs place learning in the Morris water maze.

Authors:  R K McNamara; R W Skelton
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.

Authors:  N J Wesensten; T J Balkin; H Q Davis; G L Belenky
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

7.  Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory.

Authors:  K Ito; Y Yamada; K Nakamura; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

8.  The interaction of substituted benzamides with brain benzodiazepine binding sites in vitro.

Authors:  R W Horton; S Lowther; J Chivers; P Jenner; C D Marsden; B Testa
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

9.  GABA-related drugs modulate the behavioral effects of lorazepam.

Authors:  J G Wettstein; R D Spealman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 10.  Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia.

Authors:  S I Ankier; K L Goa
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.